Warts Therapeutics Market is expected to reach US$ 2,314.60 Million by 2028

The warts therapeutics market size is expected to reach US$ 2,314.60 million by 2028, registering at a CAGR of 3.4% from 2021 to 2028, according to a new research study conducted by The Insight Partners.

Genital Warts Type to Lead Warts Therapeutics Market During 2021–2028

The report highlights the key factors driving the market growth and prominent players with their developments in the market. The growth of the warts therapeutics market is primarily attributed to the rising prevalence of human papillomavirus infections and recurrence of genital warts, and development of new products. However, poor diagnostics scenario in low-income countries hinders the market growth.

Based on type, the warts therapeutics market is segmented into common warts, genital warts, flat warts, and others. The common warts segment is the largest shareholder in the market; however, the genital warts segment is expected to register the highest CAGR in the market during the forecast period.

Bausch Health Companies Inc.; Nielsen BioSciences, Inc.; Euro Vital Pharma GmbH, Cipla Inc.; Koninklijke Utermöhlen NV; Novan, Inc.; Scholl's Wellness Company; TEVA PHARMACEUTICAL INDUSTRIES LTD; Verrica Pharmaceuticals Inc.; GlaxoSmithKline plc.; and AIM ImmunoTech Inc are among leading companies operating in the warts therapeutics market.

Warts Therapeutics Market, by Region, 2021 (%)

---

Warts Therapeutics Market Size, Growth | Forecast 2022, 2028

Download Free Sample

---

Warts Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Common Warts, Genital Warts, Flat Warts, and Others), Treatment (Physical Destruction, Immunomodulation, and Chemical Destruction), and End User (Hospitals, Homecare, Specialty Clinics, and Others)

The report segments warts therapeutics market as follows:

The warts therapeutics market has been segmented on the bases of type, treatment, and end user. Based on type, the market is segmented into common warts, genital warts, flat warts, and others. Based on treatment, the market is segmented into physical destruction, immunomodulation, and chemical destruction. The market for physical destruction is further segmented into cryotherapy, surgical removal, and laser treatment. Moreover, the market for the immunomodulation is further segmented into interferons, retinoids, and zinc. The warts therapeutics market for chemical destruction is further segmented into bleomycin, cantharidin, salicylic acid, and others. By end user, the warts therapeutics market is subsegmented into hospitals, homecare, specialty clinics, and others.

By Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific (APAC)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of APAC
• Middle East and Africa (MEA)
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of MEA
• South and Central America (SCAM)
  • Brazil
  • Argentina
  • Rest of SCAM

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com